About
IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.
- Name
- iShares Biotechnology ETF
- Index tracked
- NYSE Biotechnology TR USD
- Type
- Equity
- Expense ratio
- 0.44%
- Management fee
- 0.44%
- Dividend policy
- Quarterly
- NAV
- USD 202.44334 (09/16/2026)
- Issued units
- 51.35M (09/16/2026)
- Listing date
- Feb 5, 2001
- Sponsor
- iShares
- Custodian
- JPMorgan Chase Bank, N.A.